Renal Cancer - Results from #2280

Hypothermia During Partial Nephrectomy for Patients with Renal Tumors: A Randomized Controlled Trial. December 28, 2020

Reconnaissance of Tumor Immune Microenvironment Spatial Heterogeneity in Metastatic Renal Cell Carcinoma and Correlation with Immunotherapy Response. December 24, 2020

Integrated Analysis of a Competing Endogenous RNA Network Reveals a Prognostic Signature in Kidney Renal Papillary Cell Carcinoma. December 24, 2020

Patient Stratification of Clear Cell Renal Cell Carcinoma Using the Global Transcription Factor Activity Landscape Derived From RNA-Seq Data. December 24, 2020

Completely laparoscopic versus open radical nephrectomy and infrahepatic tumor thrombectomy: Comparison of surgical complexity and prognosis. December 23, 2020

Risk prediction for renal cell carcinoma: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) prospective cohort study. December 23, 2020

MicroRNA Signature in Renal Cell Carcinoma. December 23, 2020

Nomogram predicting 30-day mortality after nephrectomy in the contemporary era: Results from the SEER database. December 22, 2020

Oligometastatic renal cell carcinoma in the palatine tonsil: successful resection using trans-oral robotic surgery. December 22, 2020

Impact of Body Mass Index on Perioperative Complications and Oncologic Outcomes in Patients Undergoing Thermal Ablation for Renal Cell Carcinoma. December 22, 2020

Novel Honokiol-eluting PLGA-based scaffold effectively restricts the growth of renal cancer cells. December 21, 2020

Comparative Assessment of the WNT/β-Catenin Pathway, CacyBP/SIP, and the Immunoproteasome Subunit LMP7 in Various Histological Types of Renal Cell Carcinoma. December 21, 2020

Impact of margin status on survival after radical nephrectomy for renal cell carcinoma. December 21, 2020

Assessing improvements in metastatic renal cell carcinoma systemic treatments from the pre-cytokine to the immune checkpoint inhibitor eras: a retrospective analysis of real-world data. December 18, 2020

Individualizing Systemic Therapies in First Line Treatment and beyond for Advanced Renal Cell Carcinoma. December 18, 2020

Oncometabolite L-2-Hydroxyglurate Directly Induces Vasculogenic Mimicry Through PHLDB2 in Renal Cell Carcinoma. December 17, 2020

Real-world Data of Nivolumab for Patients With Advanced Renal Cell Carcinoma in the Netherlands: An Analysis of Toxicity, Efficacy, and Predictive Markers. December 17, 2020

Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma. December 17, 2020

Impact of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma receiving systemic tyrosine kinase inhibitor therapy: A multicenter retrospective study. December 16, 2020

Treatment strategy for papillary renal cell carcinoma type 2: a case series of seven patients treated based on next generation sequencing data. December 16, 2020

Page 115 of 456